KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) EBT (2016 - 2025)

Historic EBT for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to $337.0 million.

  • Labcorp Holdings' EBT rose 6001.9% to $337.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 7510.34%. This contributed to the annual value of $959.5 million for FY2024, which is 6865.88% up from last year.
  • Latest data reveals that Labcorp Holdings reported EBT of $337.0 million as of Q3 2025, which was up 6001.9% from $304.7 million recorded in Q2 2025.
  • Labcorp Holdings' 5-year EBT high stood at $1.0 billion for Q1 2021, and its period low was -$147.1 million during Q4 2023.
  • Over the past 5 years, Labcorp Holdings' median EBT value was $297.4 million (recorded in 2024), while the average stood at $350.5 million.
  • As far as peak fluctuations go, Labcorp Holdings' EBT surged by 48169.59% in 2021, and later plummeted by 154215.69% in 2023.
  • Quarter analysis of 5 years shows Labcorp Holdings' EBT stood at $447.0 million in 2021, then plummeted by 97.72% to $10.2 million in 2022, then tumbled by 1542.16% to -$147.1 million in 2023, then skyrocketed by 224.95% to $183.8 million in 2024, then surged by 83.35% to $337.0 million in 2025.
  • Its EBT stands at $337.0 million for Q3 2025, versus $304.7 million for Q2 2025 and $275.2 million for Q1 2025.